Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
- PMID: 18700216
- PMCID: PMC2801826
- DOI: 10.1192/bjp.bp.107.042630
Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
Abstract
Background: Violence is an uncommon but significant problem associated with schizophrenia.
Aims: To compare antipsychotic medications in reducing violence among patients with schizophrenia over 6 months, identify prospective predictors of violence and examine the impact of medication adherence on reduced violence.
Method: Participants (n=1445) were randomly assigned to double-blinded treatment with one of five antipsychotic medications. Analyses are presented for the intention-to-treat sample and for patients completing 6 months on assigned medication.
Results: Violence declined from 16% to 9% in the retained sample and from 19% to 14% in the intention-to-treat sample. No difference by medication group was found, except that perphenazine showed greater violence reduction than quetiapine in the retained sample. Medication adherence reduced violence, but not in patients with a history of childhood antisocial conduct. Prospective predictors of violence included childhood conduct problems, substance use, victimisation, economic deprivation and living situation. Negative psychotic symptoms predicted lower violence.
Conclusions: Newer antipsychotics did not reduce violence more than perphenazine. Effective antipsychotics are needed, but may not reduce violence unrelated to acute psychopathology.
Comment in
-
Antipsychotic medications do not differ substantially in ability to reduce violent behaviour in people with schizophrenia.Evid Based Ment Health. 2009 Feb;12(1):13. doi: 10.1136/ebmh.12.1.13. Evid Based Ment Health. 2009. PMID: 19176772 No abstract available.
References
-
- Walsh E, Buchanan A, Fahy T. Violence and schizophrenia: examining the evidence. Br J Psychiatry 2002; 180: 490–5. - PubMed
-
- Swanson JW, Swartz MS, Elbogen EB. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Schizophr Bull 2004; 30: 3–20. - PubMed
-
- Buckley PF. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry 1999; 60: 52–60. - PubMed
-
- Buckley PF, Bartell J, Donenwirth K, Lee S, Torigoe F, Schulz SC. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995; 23: 607–11. - PubMed
-
- Citrome L, Krakowski M, Greenberg WM, Andrade E, Volavka J. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder. J Clin Psychiatry 2001; 62: 901. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
